6-K 1 ea0220078-6k_haoxi.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2024

 

Commission File Number: 001-41933

 

Haoxi Health Technology Limited

 

Room 801, Tower C, Floor 8, Building 103, Huizhongli, Chaoyang District

Beijing, China

+86-10-13311587976

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F ☒      Form 40-F ☐

 

 

 

 

 

 

EXHIBIT INDEX

 

Number   Description of Exhibit
99.1   Press Release – Haoxi Health Technology Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Haoxi Health Technology Limited
     
Date: November 6, 2024 By: /s/ Zhen Fan
  Name:  Zhen Fan
  Title: Chief Executive Officer

 

2